At the time of writing, Progyny Inc [PGNY] stock is trading at $25.86, up 4.15%. An important factor to consider is whether the stock is rising or falling in short-term value. The PGNY shares have gain 5.34% over the last week, with a monthly amount glided 32.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Progyny Inc [NASDAQ: PGNY] stock has seen the most recent analyst activity on November 12, 2025, when KeyBanc Capital Markets upgraded its rating to an Overweight but kept the price target unchanged to $30 for it. Previously, Leerink Partners upgraded its rating to Outperform on July 08, 2025, and kept the price target unchanged to $28. On December 02, 2024, downgrade downgraded it’s rating to Neutral but maintained its price target of $17 on the stock. Truist downgraded its rating to a Hold and decreased its price target to $19 on November 13, 2024. JMP Securities downgraded its rating to a Mkt Perform. Leerink Partners downgraded its rating to Market Perform for this stock on August 07, 2024, and downed its price target to $25. In a note dated August 07, 2024, Canaccord Genuity downgraded a Hold rating on this stock and revised its target price from $37 to $24.
For the past year, the stock price of Progyny Inc fluctuated between $13.86 and $27.25. Currently, Wall Street analysts expect the stock to reach $28.33 within the next 12 months. Progyny Inc [NASDAQ: PGNY] shares were valued at $25.86 at the most recent close of the market. An investor can expect a potential return of 9.55% based on the average PGNY price forecast.
Analyzing the PGNY fundamentals
According to Progyny Inc [NASDAQ:PGNY], the company’s sales were 1.27B for trailing twelve months, which represents an 9.32% jump. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.12 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.95 points at the first support level, and at 24.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.40, and for the 2nd resistance point, it is at 26.95.
Ratios To Look Out For
It is important to note that Progyny Inc [NASDAQ:PGNY] has a current ratio of 2.96. On the other hand, the Quick Ratio is 2.96, and the Cash Ratio is 0.6. Considering the valuation of this stock, the price to sales ratio is 1.76, the price to book ratio is 3.98 and price to earnings (TTM) ratio is 40.94.
Transactions by insiders
Recent insider trading involved Livingston Mark S., CHIEF FINANCIAL OFFICER, that happened on Nov 17 ’25 when 21303.0 shares were sold. Officer, Livingston Mark S. completed a deal on Nov 17 ’25 to buy 21303.0 shares. Meanwhile, CHIEF EXECUTIVE OFFICER Anevski Peter bought 79500.0 shares on Nov 13 ’25.
